Search
Menu
Home
HTB
2024
November
November 2024
Contents
Special reports
Unheard: The medical practice of silencing – by Dr Rageshri Dhairyawan
Conference reports
Glasgow HIV Congress 2024: Introduction and links
Once-weekly oral ART with islatravir plus lenacapavir sustains results to week 48
EACS guidelines: New format and contents includes chemsex
Double dose start for oral PrEP in new EACS guidelines – rapid protection in two hours
Future PrEP and new results on lenacapavir from PURPOSE 1 and 2 – does HIV exposure explain incident cases?
Liverpool University Drug Interaction website recognised for global impact on research and care
HCV coinfection approaches zero in Spain: but cirrhosis and reinfection among gay men are still significant even with high rates of cure
Dolutegravir/lamivudine vs triple ART have similar efficacy in advanced HIV infection with CD4 <200 and viral load >100,000
Treatment access
Management of drug resistance to integrase inhibitors: results from an international perinatal virtual clinic
mpox
Mpox breakthrough cases after two doses of the MVA-BN vaccine
Coinfections and complications
Bipolar disorder in people living with HIV
On the web
WHO toolkit to strengthen engagement of health workers in emergency responses
HTB RSS
Early access
CROI 2025: Reducing Biktarvy from daily to only once, twice or three times a week
17 March 2025
CROI 2025: Potential for once-yearly lenacapavir injections
16 March 2025
CROI 2025: RIO study: Dual-bNABs keep viral load undetectable off-ART – plus a potential first case of vaccine-like HIV remission
12 March 2025
CROI 2025: Introduction to this year’s conference
9 March 2025
All early access reports
Current issues
March 2025
February 2025
January 2025
Back issues
Special report
Global update: 90-day review ended early and cancelled 10,000 grants, millions of people will suffer
1 March 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate